Headlines about Spectranetics (NASDAQ:SPNC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Spectranetics earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave news headlines about the medical equipment provider an impact score of 45.8451504813099 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Several analysts have recently weighed in on the company. Needham & Company LLC downgraded Spectranetics from a “buy” rating to a “hold” rating in a report on Friday, August 4th. Stifel Nicolaus cut Spectranetics from a “buy” rating to a “hold” rating in a report on Thursday, August 3rd. Finally, Guggenheim lowered Spectranetics from a “buy” rating to a “neutral” rating in a research note on Friday, August 4th. Ten analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $35.36.
Shares of Spectranetics (SPNC) opened at $38.45 on Friday. The company has a debt-to-equity ratio of 7.61, a quick ratio of 1.43 and a current ratio of 1.92. Spectranetics has a 52 week low of $19.80 and a 52 week high of $38.55.
The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads.
Receive News & Ratings for Spectranetics Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectranetics Corp and related companies with MarketBeat.com's FREE daily email newsletter.